Type IV or asymptomatic inflammation, due to its lack of symptoms in patients, can only be diagnosed based on increased leukocytes in biopsy samples taken after a prostate-specific antigen (PSA) test in prostate cancer screens (Porcaro et al., 2015). The gene discussed is KLK3; the disease is prostate carcinoma.